Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Cisplatin|DRUG: Cyclophosphamide|DRUG: Doxorubicin
Sponsor: Beth Israel Deaconess Medical Center